July 21, 2021
Article
While a significantly reduced effectiveness was seen with 1 dose, only a small reduction was observed after 2.
Impaired resilience was found to be associated with loneliness.
July 16, 2021
The designation moves the companies' PDUFA date up to January 2022, when BNT162b2 may become the first regulated COVID-19 vaccine.
July 15, 2021
The Johnson & Johnson vaccine showed neutralizing antibody responses against variants of concern.
Before other states adopt randomly-selected payouts for COVID-19 vaccine administration, further research is needed into these lotteries’ effects on potential increases in vaccination rates.
July 13, 2021
Those taking methotrexate had lower seroconversion rates compared to controls.
A meeting between developers and federal experts was inconclusive to the necessity of a third mRNA dose for COVID-19.
July 12, 2021
The CDC announced 100 preliminary cases of Guillain-Barré syndrome following vaccine administration.
While infection risk is not eliminated, the vaccine still provided significant protection.
This serious adverse event has been linked with COVID-19 shots from AstraZeneca and Janssen.
